Showing results (1-10 of 279) with videos related to
Sort By:
Pageof 28
Clinics and Research in Hepatology and Gastroenterology|June 19, 2018
Cameron lesions: A still overlooked diagnosis. Case report and systematic review of literatureA Zullo, R Manta, V De Francesco, et al.Acta Gastro-Enterologica Belgica|June 16, 2022
First-line therapies for H. pylori infection in Italy: a pooled-data analysisV De Francesco, A Zullo, R Manta, et al.Alimentary Pharmacology & Therapeutics|June 14, 2005
High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled studyA Zullo, L Gatta, V De Francesco, et al.Alimentary Pharmacology & Therapeutics|September 9, 2008
Duplicate breath testing to confirm eradication of Helicobacter pylori: incremental benefit and cost in 419 patientsN Vakil, A Zullo, C Ricci, et al.Alimentary Pharmacology & Therapeutics|June 21, 2005
A 10-day levofloxacin-based triple therapy in patients who have failed two eradication coursesL Gatta, A Zullo, F Perna, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 25, 2007
Levofloxacin-based triple therapy for Helicobacter pylori re-treatment: role of bacterial resistanceF Perna, A Zullo, C Ricci, et al.Alimentary Pharmacology & Therapeutics|June 2, 2007
Primary antibiotic resistance in Helicobacter pylori strains isolated in northern and central ItalyA Zullo, F Perna, C Hassan, et al.Analytical and Quantitative Cytology and Histology|March 9, 1999
Measurement variability and diagnostic sensitivity of gastric mucosal inflammatory cell morphometryP Ballanti, A Zullo, V Rinaldi, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 12, 2002
Two new treatment regimens for Helicobacter pylori eradication: a randomised studyV De Francesco, A Zullo, C Hassan, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 27, 2007
Tumour necrosis factor alpha down-regulation parallels inflammatory regression in ulcerative colitis patients treated with infliximabC Hassan, E Ierardi, O Burattini, et al.Pageof 28